London, ON – January 16, 2020 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announces the completion of their Phase IIa Venous Leg Ulcer trial and that all North American sites have been soft closed and global database lock is expected in early March […]
Cambridge, MA – November 6, 2019 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announces it has been awarded a Phase II neurological movement disorder trial. “All of us at Stiris are excited to embark on this rare movement disorder trial. Our highly experienced […]
London, ON and Cambridge, MA – May 13th, 2019 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announce the addition of Carrie Hamilton, BSc. to the Clinical team. Carrie joins the company as the Director, Clinical Science and brings 30 years’ of biopharmaceutical experience […]
London, ON – March 6, 2019 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announce the successfully completion of their Phase I Zika virus trial. “We are thankful to have had the opportunity to work on this exciting trial. We look forward to hearing […]
We are pleased to announce that the President and CEO of Stiris Research, Shantal Feltham, is the recipient of the 2019 Women of Excellence Award in Entrepreneurship. This award, presented every 2 years, honours women who have contributed to the growth of their community, and whose accomplishments inspire others to achieve their goals. Shantal’s passion, […]
London, ON – January 14th, 2019 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announced successfully completing enrollment ahead of the Australian biotech’s corporate milestone target on their Phase 1b Open label study in Uveal Melanoma metastatic to liver. The last patient was screened […]
Cambridge, MA – January 7th, 2019 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announce the addition of Glenn Block to its Business Development team. Glenn Block joins the company as the Executive Director, Sales & Marketing and brings 20+ years’ commercial experience in […]
London, ON – December 18, 2018 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announce that the Australian biotech they are collaborating with on a pancreatic cancer program received a favourable FDA response following review of safety data compiled for research being done in […]
London, ON – August 3, 2018 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announce it has entered into a Master Services Agreement (the “MSA”) with a Canadian biotech company for work on their international prospective clinical trial involving a novel cancer therapy guidance […]
London, ON – May 24, 2018 – Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announces the completion of all 10 Closeout Visits (COVs) of North American Investigative Sites who participated in the extension phase of a Phase II Hormone-Refractory Castrate-Resistant Prostate Cancer (HRCPC) study. […]